as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
4.80%
Downside
3.24%
Upside
52 Week's Low
52 Week's High
67.65%
Downside
10.29%
Upside
Check Immatics Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-1.902
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-78.3M
Revenue (TTM)
130.1M
Profit Margin
-57.45%
Return On Equity TTM
-17.54%
Compare market cap, revenue, PE, and other key metrics of Immatics Nv with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | -2.76% | NA | -57.45% | |
| BUY | $60.0B | 247.38% | 1448.9 | 1.36% | |
| NA | $43.9B | NA | 717.29 | 1.38% | |
| BUY | $110.9B | 96.07% | 30.76 | 31.35% | |
| BUY | $73.0B | 28.87% | 16.61 | 32.13% |
The Immatics Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Immatics Nv investment value today
Current value as on today
₹1,30,089
Returns
₹30,089
(+30.09%)
Returns from Immatics Nv Stock
₹24,847 (+24.85%)
Dollar Returns*
₹5,242 (+5.24%)
Based on 14 analysts
92.86%
Buy
7.14%
Hold
0.00%
Sell
Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Immatics Nv. Average target price of $16.29
Get share price movements and forecasts by analysts on Immatics Nv.
What analysts predicted
37.38%UPSIDE
Target Price
$16.29
Current Price
$10.2
Analyzed by
14 Analysts
Target
$16.29
Immatics Nv target price $16.29, a slight upside of 37.38% compared to current price of $10.2. According to 14 analysts rating.
Search interest for Immatics Nv Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, IMTX stock has moved up by 13.0%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 82.4% return, outperforming this stock by 83.0%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 68.5%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 56.25M → 4.73M (in $), with an average decrease of 70.7% per quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 44.86M → -70.34M (in $), with an average decrease of 132.7% per quarter
| Organisation | Immatics Nv |
| Headquarters | Paul-Ehrlich-Strasse 15, Tübingen, Germany, 72076 |
| Industry | Health Technology |
| CEO | Dr. Harpreet Singh Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Toni Weinschenk Ph.D. | Co-Founder & Chief Innovation Officer |
Mr. Edward A. Sturchio | General Counsel & Secretary |
Dr. Hans-Georg Rammensee Ph.D. | Co-Founder & Member of the Scientific Advisory Board |
Dr. Harpreet Singh Ph.D. | CEO, MD, Member of Management Board & Executive Director |
Mr. Steffen Walter Ph.D. | Chief Operations Officer |
Dr. Carsten Reinhardt M.D., Ph.D. | Chief Development Officer |
Dr. Rainer Kramer Ph.D. | Chief Business Officer & Site Head Munich |
Mr. Cedrik M. Britten M.D. | Chief Medical Officer |
Mr. Jordan Silverstein | Head of Strategy |
Dr. Venkat Ramanan Ph.D. | Chief Financial Officer |
Immatics Nv share price today is $10.2 as on at the close of the market. Immatics Nv share today touched a day high of $10.53 and a low of $9.71.
Immatics Nv share touched a 52 week high of $11.25 on and a 52 week low of $3.3 on . Immatics Nv stock price today i.e. is closed at $10.2,which is 9.33% down from its 52 week high and 209.09% up from its 52 week low.
Immatics Nv market capitalisation is $0.00T as on .
Indian investors can start investing in Immatics Nv (IMTX) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Immatics Nv stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immatics Nv share’s latest price of $10.2 as on November 15, 2025 at 2:29 am IST, you will get 0.9804 shares of Immatics Nv. Learn more about
fractional shares .
Immatics Nv stock has given -2.76% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?